PKO Investment Management Joint Stock Co Has $642,000 Stake in Agilent Technologies, Inc. $A

PKO Investment Management Joint Stock Co cut its stake in Agilent Technologies, Inc. (NYSE:A) by 41.2% in the third quarter, Holdings Channel.com reports. The firm owned 5,000 shares of the medical research company’s stock after selling 3,500 shares during the quarter. PKO Investment Management Joint Stock Co’s holdings in Agilent Technologies were worth $642,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently modified their holdings of A. Resona Asset Management Co. Ltd. boosted its position in shares of Agilent Technologies by 6.2% during the second quarter. Resona Asset Management Co. Ltd. now owns 98,400 shares of the medical research company’s stock worth $11,631,000 after buying an additional 5,767 shares during the period. TrueMark Investments LLC bought a new stake in Agilent Technologies in the 2nd quarter valued at approximately $1,999,000. Nuance Investments LLC boosted its position in Agilent Technologies by 13.5% during the 2nd quarter. Nuance Investments LLC now owns 80,698 shares of the medical research company’s stock worth $9,523,000 after acquiring an additional 9,628 shares during the last quarter. Fenimore Asset Management Inc grew its stake in shares of Agilent Technologies by 2.7% during the 2nd quarter. Fenimore Asset Management Inc now owns 180,880 shares of the medical research company’s stock worth $21,346,000 after acquiring an additional 4,823 shares in the last quarter. Finally, Arrowstreet Capital Limited Partnership raised its holdings in shares of Agilent Technologies by 472.5% in the second quarter. Arrowstreet Capital Limited Partnership now owns 221,993 shares of the medical research company’s stock valued at $26,197,000 after purchasing an additional 183,220 shares during the last quarter.

Analyst Ratings Changes

Several research analysts recently commented on A shares. Rothschild Redb upgraded shares of Agilent Technologies to a “strong-buy” rating in a report on Wednesday, October 8th. Weiss Ratings restated a “hold (c+)” rating on shares of Agilent Technologies in a research note on Monday, December 29th. Rothschild & Co Redburn assumed coverage on Agilent Technologies in a research report on Wednesday, October 8th. They issued a “buy” rating and a $165.00 target price on the stock. JPMorgan Chase & Co. upped their target price on Agilent Technologies from $165.00 to $180.00 and gave the stock an “overweight” rating in a report on Tuesday, November 25th. Finally, The Goldman Sachs Group began coverage on Agilent Technologies in a research report on Tuesday, December 9th. They set a “buy” rating and a $170.00 price target for the company. One equities research analyst has rated the stock with a Strong Buy rating, twelve have issued a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat.com, Agilent Technologies currently has an average rating of “Moderate Buy” and an average price target of $163.31.

Agilent Technologies Stock Down 1.0%

Agilent Technologies stock opened at $146.47 on Wednesday. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.96 and a quick ratio of 1.52. The company’s 50-day moving average is $144.62 and its 200-day moving average is $133.04. The firm has a market capitalization of $41.52 billion, a PE ratio of 32.05, a P/E/G ratio of 4.30 and a beta of 1.29. Agilent Technologies, Inc. has a fifty-two week low of $96.43 and a fifty-two week high of $160.27.

Agilent Technologies (NYSE:A) last issued its earnings results on Monday, November 24th. The medical research company reported $1.59 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.58 by $0.01. The business had revenue of $1.86 billion during the quarter, compared to the consensus estimate of $1.83 billion. Agilent Technologies had a net margin of 18.75% and a return on equity of 25.20%. Agilent Technologies’s revenue was up 9.4% on a year-over-year basis. During the same period last year, the business posted $1.46 EPS. Agilent Technologies has set its Q1 2026 guidance at 1.350-1.380 EPS and its FY 2026 guidance at 5.860-6.000 EPS. Sell-side analysts anticipate that Agilent Technologies, Inc. will post 5.58 earnings per share for the current year.

Agilent Technologies Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, January 28th. Stockholders of record on Tuesday, January 6th will be paid a dividend of $0.255 per share. The ex-dividend date is Tuesday, January 6th. This represents a $1.02 annualized dividend and a dividend yield of 0.7%. This is an increase from Agilent Technologies’s previous quarterly dividend of $0.25. Agilent Technologies’s dividend payout ratio is presently 22.32%.

Insider Buying and Selling

In related news, VP Rodney Gonsalves sold 3,000 shares of the stock in a transaction on Wednesday, November 26th. The stock was sold at an average price of $154.99, for a total value of $464,970.00. Following the sale, the vice president owned 31,846 shares in the company, valued at approximately $4,935,811.54. This represents a 8.61% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Padraig Mcdonnell sold 12,490 shares of the firm’s stock in a transaction on Wednesday, November 12th. The shares were sold at an average price of $150.00, for a total value of $1,873,500.00. Following the sale, the chief executive officer directly owned 33,448 shares of the company’s stock, valued at $5,017,200. This represents a 27.19% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold a total of 16,401 shares of company stock worth $2,468,962 over the last three months.

About Agilent Technologies

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.